PZENA INVESTMENT MANAGEMENT LLC, a registered investment adviser, initiated a new position in CVS Health Corporation (NYSE:CVS) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 15,286,467 shares of the Healthcare company, valued at approximately $1.2B as of the filing date.
CVS Health Corporation's stock currently trades at $77.41 with a market capitalization of $102.6B.